Skip to end of metadata
Go to start of metadata

Welcome

The Bejerano Lab developed the Mendelian Clinically Applicable Pathogenicity (M-CAP) Score. M-CAP is the first pathogenicity classifier for rare missense variants in the human genome that is tuned to the high sensitivity required in the clinic (see Table). By combining previous pathogenicity scores (including SIFT, Polyphen-2 and CADD) with novel features and a powerful model, we attain the best classifier at all thresholds, reducing a typical exome/genome rare (<1%) missense variant (VUS) list from 300 to 120, while never mistaking 95% of known pathogenic variants as benign. Further details can be found here.

 

M-CAP FAQ

Q1. Which mutations does M-CAP score?

M-CAP scores rare, missense variants from the Ensemble 75 Gene Set.

Q2. How do you distinguish common variants from rare variants?

The frequency of a base pair is determine by examining the ExAC and 1000 genomes project control populations. A base is defined as common if it has greater than 1% allele frequency in ExAC, 1000 genomes or in any subpopulation in the two datasets. 

Q3. How is the mutation type selected if the mutation occurs on a gene with multiple isoforms, and the type of mutation corresponding to different isoforms is different?

In this case, we follow a hierarchy whose order is (1) nonsynonymous, (2) stopgain, (3) stoploss, (4) synonymous, (5) noncoding. That is, if multiple isoforms with different corresponding mutation types exist, the mutation type that comes first in the hierarchy will be displayed. That is, if the mutation corresponds to nonsynonymous in one isoform and stopgain in another, the mutation type displayed will be nonsynonymous. Nonsynonymous is the top of the hierarchy because the classifier scores only nonsynonymous variants, and stopgain and stoploss are prioritized over synonymous variants as they are thought to be more likely pathogenic than synonymous mutations.

Q4. How are M-CAP scores assigned?

M-CAP scores are between 0 and 1. A threshold of 0.025 is used to separate likely benign from possibly pathogenic variants. The threshold of 0.025 corresponds with a 95% confidence threshold that variants marked likely benign are in fact benign.



 

 

  • No labels